Recombinant Anti-CD28 x Anti-MUC1 Bispecific Antibody (Tandem scFv) is designed to be expressed as a scFv from an anti-CD28 antibody variable domains fused with a scFv from an anti-MUC1 antibody variable domains. It contains a His-tag at the C/N terminus for affinity purification. The BsAb exits as monomer in reducing and non-reducing conditions. This BsAb can retarget T cells to tumor cells. It is designed for the research of Pancreatic cancer; Ovarian cancer; Breast cancer; Bile duct cancer (BDC) therapy.
There are currently no customer reviews or questions for Recombinant Human Anti-CD28 x Anti-MUC1 Bispecific Antibody (Tandem scFv) (BSFV-H236). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS